NATURE BIOTECHNOLOGY, an esteemed journal published by NATURE PORTFOLIO, stands at the forefront of innovation in biotechnological research since its inception in 1989. With an impressive impact factor reflecting its preeminent status—ranked in the Q1 quartile across multiple categories including Applied Microbiology, Bioengineering, Biomedical Engineering, Biotechnology, and Molecular Medicine—this journal is a pivotal resource for researchers and professionals aiming to advance the boundaries of biotechnology. The journal is highly regarded, boasting Scopus rankings in the 99th percentile within its categories. NATURE BIOTECHNOLOGY provides a platform for disseminating cutting-edge findings, with open access options that enhance the visibility and accessibility of its content to a global audience. The scope of the journal encapsulates a diverse range of topics from genetic engineering to pharmaceutical developments, ensuring comprehensive coverage of emerging biotechnological advances. As the field continues to evolve, NATURE BIOTECHNOLOGY remains committed to publishing groundbreaking research that shapes the future of science and industry.

Biocybernetics and Biomedical Engineering, published by ELSEVIER in the Netherlands, is a prestigious journal that stands at the forefront of the intersecting fields of biomedical engineering and artificial intelligence. With an impressive Impact Factor that places it in the Q1 category for Biomedical Engineering, this journal not only ranks 17th out of 303 in Scopus but also boasts a remarkable percentile ranking of 94th, highlighting its influence and relevance within the scientific community. Since its inception in 2008, Biocybernetics and Biomedical Engineering has aimed to publish cutting-edge research that integrates principles of cybernetics with technological advancements in health care, thereby fostering innovations that improve patient outcomes. Dedicated to advancing knowledge in biomedical technology, the journal serves as a vital resource for researchers, professionals, and students seeking to explore the latest developments and methodologies in the field.

The Journal of Mechanics in Medicine and Biology, published by World Scientific Publishing Co Pte Ltd, serves as a critical platform for interdisciplinary research at the intersection of engineering and biomedical sciences. With an ISSN of 0219-5194 and E-ISSN of 1793-6810, this esteemed journal has been dedicated to exploring the mechanical principles that govern biological systems since its inception in 2008. Based in Singapore, it addresses a diverse range of topics, from biomaterials to biomechanics, contributing valuable insights into the field’s evolving landscape. Although currently positioned in Q4 of Biomedical Engineering according to the 2023 category quartiles, it is poised for growth and increased visibility within the scientific community, fostering innovation and collaboration among researchers, professionals, and students alike. The journal emphasizes the importance of cutting-edge research and its practical implications, making it a vital resource for those striving to enhance the future of medical technologies and biological understanding.

Current Opinion in Biotechnology, published by Elsevier Science Ltd, is a premier academic journal dedicated to providing critical insights and evaluations on emerging trends and developments in the ever-evolving fields of biotechnology and bioengineering. With an impressive impact factor and ranking in the Q1 quartile across bioengineering, biomedical engineering, and biotechnology, this journal serves as an indispensable resource for researchers, professionals, and students alike. Spanning from 1990 to 2024, the journal facilitates scholarly discourse by featuring concise reviews authored by leading experts, covering cutting-edge topics and innovative technologies. With a strong presence in renowned databases such as Scopus, where it ranks within the top percentiles in multiple categories, Current Opinion in Biotechnology not only contributes to the academic community but also impacts industry practices, making it a highly relevant platform for those looking to stay at the forefront of biotechnology innovation.

BIOTECHNOLOGY AND BIOENGINEERING, published by Wiley, is a leading journal in the domains of applied microbiology, biotechnology, and bioengineering. With an ISSN of 0006-3592 and E-ISSN of 1097-0290, this journal has established itself as an essential resource for researchers, professionals, and students aiming to advance their knowledge and stay updated on cutting-edge innovations and methodologies in biotechnology. The journal has a commendable impact factor, and it is ranked in the second quartile (Q2) across multiple categories for 2023. This positions it favorably among its peers, underscoring its significance in the scientific community; for example, it ranks 23rd out of 127 in the field of Applied Microbiology and Biotechnology. As a hub of critical research findings and technological advancements, BIOTECHNOLOGY AND BIOENGINEERING invites contributions that push the boundaries of biotechnological applications, fostering a deeper understanding and development of sustainable solutions to current global challenges.

Bioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.

Computational and Structural Biotechnology Journal is a premier open-access journal published by Elsevier, focusing on the intersection of computer science and molecular biology. Since its inception in 2012, the journal has established itself as a leading platform for innovative research, featuring groundbreaking studies in biochemistry, biophysics, biotechnology, and genetics. With a remarkable Q1 ranking in multiple categories, including Biochemistry and Genetics, it stands out for its high impact, evidenced by its strong Scopus ranking percentile scores. As a vital resource for researchers, professionals, and students, the journal aims to foster the dissemination of essential findings that leverage computational techniques to explore complex biological systems. In a rapidly evolving scientific landscape, Computational and Structural Biotechnology Journal serves as an indispensable resource for those looking to contribute and stay abreast of major advancements in the field.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

Computer Methods and Programs in Biomedicine, published by ELSEVIER IRELAND LTD, is a leading journal at the intersection of computer science and biomedical research. With an impressive impact factor evidenced by its Q1 rankings in multiple categories—Computer Science Applications, Health Informatics, and Software—this journal ranks highly among peer publications, showcasing its significance in advancing interdisciplinary research. Covering a wide array of topics since its inception in 1985, it is particularly crucial for those invested in the innovation of computational methods applied to the biomedical field. The journal has established a strong reputation, with Scopus rankings placing it in the top percentiles across its relevant sectors, including the 14th position out of 138 in Health Informatics. Researchers, practitioners, and students looking to explore current trends, methodologies, and advancements in biomedical applications of computer science will find this journal an invaluable resource.

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.